001060.KS
JW Pharmaceutical Corporation [001060.KS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
001060.KS Stock Summary
In the News
001060.KS Financial details
Company Rating
-
Market Cap
702.51B
Income
37.01B
Revenue
748.53B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
1.2K
Optionable
No
Shortable
Yes
Earnings
08 May 2024
P/E
35.65
Forward P/E
-
PEG
27.97
P/S
1.12
P/B
3.66
P/C
-
P/FCF
28.47
Quick Ratio
-
Current Ratio
1.16
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.43K
EPS next Y
-
EPS next Q
-
EPS this Y
18.69%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
7.92%
Revenue Q/Q
11.3%
EPS Q/Q
-234.82%
-
-
-
-
SMA20
-1.98%
SMA50
7.94%
SMA100
-12.9%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
10%
ROC
0.28%
Gross Margin
45%
Oper. Margin
13%
Profit Margin
3%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
20245.098-51470.59
52W High
-47.15%
52W Low
+34.35%
RSI
53
Rel Volume
0.23
Avg Volume
150.63K
Volume
35.06K
Perf Week
1.68%
Perf Month
9.24%
Perf Quarter
-15.13%
Perf Half Y
1.3%
-
-
-
-
Beta
0.607
-
-
Volatility
416.13%, 852.46%
Prev Close
-2.16%
Price
27200
Change
-3.2%
Company Profile
- Volume Average 150.63K
- Market Capitalization 702.51B
- Employee 1.2K
- CEO Mr. Young-Sub Shin
- Headquarters Seoul,KR
- IPO Date 2005-09-29
-
Website
https://www.jw-pharma.co.kr 
JW Pharmaceutical Corporation develops, manufactures, and sells medicines and medical supplies in Japan and internationally. It offers products in the areas of cardiovascular, gastrointestinal, urinary, oral hypoglycemic, antibiotics, anti-fungal, Ob and Gy, renal, CNS, anti-anemic, respiratory, rheumatic arthritis, anticancer, anesthetic, antidotes, amino acids, TPN, and others. The company was founded in 1945 and is headquartered in Seoul, South Korea.
